Last reviewed · How we verify

NCT06713278

Tension-Type Headache and Masseter Thickness in Fibromyalgia

Completed Last updated 4 December 2024
What this trial tests

trial testing masseter muscle thickness measurement in Fibromyalgia in 94 participants. Completed in 2 December 2024.

Timeline
15 May 2024
Primary endpoint
2 December 2024
2 December 2024

Quick facts

Lead sponsorAnkara City Hospital Bilkent
StatusCompleted
Study typeOBSERVATIONAL
Enrollment94
Start date15 May 2024
Primary completion2 December 2024
Estimated completion2 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 18 to 65, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the relationship between tension-type headaches and masseter muscle thickness in women with fibromyalgia syndrome (FMS) and to explore the potential for new therapeutic approaches in the treatment of both headaches and FMS. Additionally, the study seeks to evaluate the impact of headaches on the quality of life in individuals with FMS. Does tension-type headache associate with increased masseter muscle thickness in women with fibromyalgia syndrome (FMS)? Does tension-type headache negatively impact the quality of life in women with FMS?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06713278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing